Global Crohn's Disease Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application

Crohn’s disease refers to long term inflammatory bowel disease, which causes inflammation of the lining of the digestive tract. It affects the large and small intestine and is generally diagnosed in persons within the age group of 20-29. It can have severe or acute outcomes. Signs and symptoms of Crohn’s disease develop slowly and gradually. Some of the common symptoms of this disease include abdominal pain and cramping, fever, fatigue, diarrhea, blood in stools, appetite and weight loss. Inflammation of skin, joints, and eyes, inflammation of the liver or bile duct, and delayed sexual development in children are some other symptoms associated with severe Crohn’s disease.
Rising number of drug therapies for Crohn’s disease and increasing demand for better diagnostics and treatment options for the auto-immune disease are some of the key factors driving the growth of the global Crohn’s disease market. In addition, rise in the number of patients suffering from auto-immune disorders in developing countries and increasing government initiatives for improving health care infrastructure are fueling the growth of the global Crohn’s disease market. However, less awareness among people about the disease is also restraining the growth of the market. Patent expiry of various useful drugs, such as remicade and humira, is also impeding the growth of the market.

Market Analysis and Insights: Global Crohn's Disease Market
The research report studies the Crohn's Disease market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Crohn's Disease market size is projected to reach US$ 11030 million by 2027, from US$ 8655.3 million in 2020, at a CAGR of 3.1% during 2021-2027.

Global Crohn's Disease Scope and Segment
The global Crohn's Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Crohn's Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
Surgery
Drug Therapy

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Abbvie
Amgen
Cambridge Antibody Technology
Janssen Biotech
Pfizer
Tillotts Pharma
Johnson & Johnson
Boehringer Ingelheim